Literature DB >> 10321399

Strategies to improve cancer screening in general practice: are guidelines the answer?

J M Young1, J E Ward.   

Abstract

BACKGROUND: GPs are ideally placed to recommend appropriate cancer screening for their patients. However, opportunities to discuss screening are often missed and screening procedures are not always recommended in accordance with national policy. The development of clinical practice guidelines represents one strategy for improving cancer screening in general practice.
OBJECTIVE: We aimed to ascertain Australian GPs' ratings of current clinical practice guidelines and their views of the likely usefulness of 18 strategies to improve cancer screening in general practice.
METHOD: A self-administered questionnaire was mailed to a national random sample of 1271 GPs in May 1996. Responders rated the usefulness of each of eight clinical practice guidelines current at the time of the survey. They then rated the usefulness of each of 18 strategies for support of cancer screening.
RESULTS: We received 855 completed questionnaires (a 67% response rate). There was greatest support for guidelines already available on breast and cervical cancer. The most popular strategy to improve cancer screening was seminars with experts in preventive care, rated as 'very useful' by 658 (77%), followed by NHMRC guidelines (597, 70%) and pamphlets for patients (587, 69%). There was less support for more innovative strategies including assessment and feedback (35%), case finding by nurse practitioners (11%) and academic detailing (10%).
CONCLUSION: Responders indicated that strategies involving passive dissemination of information would be most useful for improving cancer screening in general practice. Identification of an effective combination of acceptable initiatives is needed.

Entities:  

Mesh:

Year:  1999        PMID: 10321399     DOI: 10.1093/fampra/16.1.66

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  5 in total

1.  Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.

Authors:  Meredith Vanstone; Winsion Chow; Laura Lester; Peter Ainsworth; Jeff Nisker; Muriel Brackstone
Journal:  Can Fam Physician       Date:  2012-05       Impact factor: 3.275

Review 2.  Barriers to GPs' use of evidence-based medicine: a systematic review.

Authors:  Sandra Zwolsman; Ellen te Pas; Lotty Hooft; Margreet Wieringa-de Waard; Nynke van Dijk
Journal:  Br J Gen Pract       Date:  2012-07       Impact factor: 5.386

3.  Impact of COVID-19 on Screening Rates for Colorectal, Breast, and Cervical Cancer: Practice Feedback From a Quality Improvement Project in Primary Care.

Authors:  Laura A Schad; Laura A Brady; Laurene M Tumiel-Berhalter; Alexandrea Bentham; Karen Vitale; Amanda Norton; Gary Noronha; Carlos Swanger; Christopher P Morley
Journal:  J Patient Cent Res Rev       Date:  2021-10-18

4.  Time-trend of melanoma screening practice by primary care physicians: a meta-regression analysis.

Authors:  Antonis Valachis; Davide Mauri; Vassiliki Karampoiki; Nikolaos P Polyzos; Ivan Cortinovis; Georgios Koukourakis; Georgios Zacharias; Apostolos Xilomenos; Maria Tsappi; Giovanni Casazza
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

5.  Family physicians' perspectives on practice guidelines related to cancer control.

Authors:  Louise Zitzelsberger; Eva Grunfeld; Ian D Graham
Journal:  BMC Fam Pract       Date:  2004-11-15       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.